Article Text
Therapeutics
Review: long acting β2 agonists are better than short acting β2 agonists in chronic asthma
Statistics from Altmetric.com
Footnotes
-
Source of funding: not stated.
-
For correspondence: Professor EH Walters, University of Tasmania, Hobart, Tasmania, Australia.